GBS supports preclinical and clinical studies evaluating the safety and efficacy of monoclonal antibodies and therapeutic compounds as well as in custom-development of cell-based platforms for mode-of action or proof of principle studies.

Our core services focus on Hemostasis and Thrombosis, Immunobiology, Cellular Bioenergetics and Neurodegeneration.